We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 9 → 11 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85% → 97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557 → 558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$685M
2
Victory Capital Management
Victory Capital Management
Texas
+$95.2M
3
American Century Companies
American Century Companies
Missouri
+$77.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$74.6M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$54.9M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$229M
2
Royal London Asset Management
Royal London Asset Management
United Kingdom
-$188M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$70.2M
4
HM
HealthCor Management
New York
-$53.3M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$52.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
JIR
551
James Investment Research
Ohio
$2K +$1.45K +19 New
AA
552
Apriem Advisors
California
$1K – – –
TDC
553
Thompson Davis & Co
Virginia
$1K – – –
NR
554
Newfound Research
Massachusetts
$1K +$533 +7 New
HCM
555
Herndon Capital Management
Georgia
$1K +$990 +13 New
SIM
556
Sonora Investment Management
Arizona
$917 – – –
AT
557
Arden Trust
Delaware
$506 -$107K -1,404 -18%
CA
558
Commerzbank Aktiengesellschaft
Germany
$351 -$46.3K -608 -12%
CCM
559
Camber Capital Management
Massachusetts
– -$42.9M -600,000 Closed
HCMT
560
Highland Capital Management (Texas)
Texas
– -$7.5M -105,000 Closed
BJCM
561
Blue Jay Capital Management
California
– -$6.64M -92,949 Closed
CSS
562
Cubist Systematic Strategies
Connecticut
– -$3M -41,995 Closed
SDIC
563
South Dakota Investment Council
South Dakota
– -$1.91M -26,700 Closed
ARTA
564
A.R.T. Advisors
New York
– -$1.9M -26,622 Closed
Squarepoint
565
Squarepoint
New York
– -$1.69M -23,671 Closed
Connor, Clark & Lunn Investment Management (CC&L)
566
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$990K -13,861 Closed
ZIG
567
Zurich Insurance Group
Switzerland
– -$943K -13,200 Closed
FI
568
FormulaFolio Investments
Michigan
– -$926K -12,954 Closed
AL
569
Airain Ltd
Guernsey
– -$791K -11,064 Closed
NAP
570
New Amsterdam Partners
New York
– -$732K -10,250 Closed
TH
571
Timber Hill
Connecticut
– -$735K -9,653 Closed
N
572
Nuveen
North Carolina
– -$647 -9,060 Closed
SM
573
Sciencast Management
New Jersey
– -$622K -8,700 Closed
TG
574
TLP Group
Illinois
– -$622K -8,700 Closed
Janney Montgomery Scott
575
Janney Montgomery Scott
Pennsylvania
– -$583K -8,155 Closed
20 21 22
23
24

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.